glutathione california board of pharmacy medical-professionals-advocating-for-continued-access-to-503a-compounding- pharmacy-drugs Glutathione USP

BPC-157 is still a research-stage compound with limited human clinical evidence, so the only responsible way to evaluate a product like this is to separate (1) what the company discloses and can document (testing, formulation, policies) from (2) what preclinical research suggests in animals or lab settings, and (3) what remains unproven in humans

U-100 markings help compare syringe listings, but they should not be used to calculate or change a dose

Dixon, S

The addition of GIP receptor activation appears to reduce nausea while enhancing metabolic effects

Alternatively, 2 mL gives 2.5 mg/mL, making a 2.5 mg dose equal to 1 mL, the full syringe